An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation
Clinical trial NCT01644396 · COMPLETED
Trial details
- NCT number
- NCT01644396
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2013-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.